Restricted accessResearch articleFirst published online 2002-03
The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions
The ACCP/SCCM American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med1992; 20: 864-74.
2.
Kirklin JK, Westaby S., Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico ADComplement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg1983; 86: 845-57.
3.
Roumen Rmh, Hendricks T., van der Ven-Jongekrijk J. et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg1993; 218: 769-76.
4.
Casey LC, Balk RA, Bone RCPlasma cytokine and endotoxin levels correlate with survival in patients with sepsis syndrome. Ann Intern Med1994; 119: 771-78.
5.
Martin C., Saux P., Mege JL, Penin G., Papazian L., Govin F.Prognostic values of serum cytokines in septic shock. IntCare Med1994; 20: 272-77.
6.
Sablotzki A. , Dehne M., Welters I. et al. Alterations of the cytokine network in patients undergoing cardiopulmonary bypass. Perfusion1997; 12: 393-403.
7.
Wan S., Marchant A., DeSmet JM et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg1996; 111: 469-77.
8.
Knaus WA, Zimmermann JE, Wagner DP et al. APACHE - acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med1981; 9: 591-97.
9.
Pilz G., Kaab S., Kreuzer E. et al. Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery. Infection1994; 22: 8-17.
10.
Kuhn C., Muller-Werdan U., Schmitt DV et al. Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS study pilot project. Eur J Cardiothorac Surg2000; 17: 30-37.
11.
Holzheimer R., Molloy RG, Goerlach G. et al. IL-6 and TNF-alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection1994; 22: 37-42.
12.
Kalfin RE, Engelman RM, Rousou A.Induction of interleukin-8 expression during cardiopulmonary bypass . Circulation1993; 88: 401-406.
13.
Sablotzki A. , Welters I., Lehman N. et al. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-β in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg1997; 11: 763-68.
14.
Nathan N., Denizot Y., Cornu E. et al. Cytokine and lipid mediator blood concentrations after coronary artery surgery. Anesth Analg1997; 85: 1240-46.
15.
Taylor KMSIRS - the systemic inflammatory response syndrome after cardiac operations . Ann Thorac Surg1996; 61: 1607-608.
16.
Hall RI, Smith MS, Rocker GMThe systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg1997; 85: 766-82.
17.
Cremer J., Martin M., Redl H.Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg1996; 61: 1714-20.
18.
Welters I., Menges T., Ballesteros M., Salsletzki A., Gorlach G., Hemplemaun G. Acute phase and opsonin response in cardiac surgery patients: influence of underlying cardiac disease. Perfusion1998; 13: 447-54.
19.
Deng MC, Wiedner M., Erren M. et al. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg1995; 9: 22-29.
20.
Van Snick J.Interleukin-6: an overview. Annu Rev Immunol1990 ; 8: 253-78.
21.
Casey LCRole of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg1993; 56: 92-96.
22.
Metinko A., Kunkel S., Standiford T. et al. Monocyte expression of interleukin-8 in response to oxidant stress. FASEB J1991; Abstracts Part 1: 194.
23.
Assicot M., Gendrel D., Carsin H. et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet1993; 341: 515-18.
24.
Meisner M., Tschaikowsky K., Schmidt J.Procalcitonin (PCT) - indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovasc Eng1996; 1: 67-72.
25.
Hensel M., Volk T., Döcke W. et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology1998; 89: 93-104.
26.
de Werra I. , Jaccard C., Corradin SB et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and pneumonia . Crit Care Med1997; 25: 607-13.
27.
Dinarello CAIL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol1999; 103: 11-24.
28.
Dinarello CABiologic basis for interleukin-1 in disease . Blood1996; 87: 2095-147.
29.
Arend WP, Malyak M., Smith MF et al. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol1994; 153: 4766-74.
30.
Puren AJ, Fantuzzi G., Gu Y. et al. Interleukin-18 (IFN-γ-inducing factor) induces IL-1β and IL-8 via TNF-α production from non-CD14+ human blood mononuclear cells . J Clin Invest1998; 101: 711-21.
31.
Whitten CW, Hill GE, Ivy R. et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesth Analg1998; 86: 28-33.